The vast majority of people with MS receive an initial diagnosis of the relapsing-remitting (RR) form of the disease ...

People with multiple sclerosis (MS) often stop taking disease-modifying therapy as they transition from relapsing-remitting MS to secondary progressive MS. This study shows that people who stop stop ...

Living with relapsing-remitting multiple sclerosis? Get answers to common questions and tips to help you talk to your doctor about it.

Today, if you’re diagnosed with relapsing-remitting MS, there’s a very high chance treatment will help you live a largely normal life. But there’s still this idea that MS is a seriously ...

RRMS disability progression rates have decreased over the years due to advances in disease-modifying therapies (DMTs), per an ...

Columnist Ahna Crum, a veteran of hurricanes, compares them with the struggles that are part of living with her multiple ...

In relapsing-remitting multiple sclerosis (MS), all of the currently available disease-modifying medications are injectables marketed for self-injection. Problems with self-injection pose a ...

There are four types of MS. They’re defined by the frequency and progression of symptoms: clinically isolated syndrome relapsing-remitting MS secondary progressive MS primary progressive MS ...

If your candidates won elections last night, do not relapse. If your candidates lost elections last night, do not relapse. If you are on the winning side, you may feel an elation that seems to ...

Patients with multiple sclerosis found that their symptoms did not worsen with intake of tolebrutinib, in the GEMINI 1 and 2 studies.

Around 8 out of 10 people with MS will have the relapsing remitting type of MS, according to the NHS. Relapsing–remitting multiple sclerosis is a chronic, disabling, neurological condition that ...

Third quarter 2024 U.S. BRIUMVI net revenue of $83.3 millionRaises full year 2024 U.S. BRIUMVI net revenue target to $300 - $305 ...